Third Rock Ventures, LLC
CIK 1600135
13F portfolio (2015-Q3)
$1.1B
Positions
5
As reported on this filer's Form 13F for 2015-Q3, filed 2015-11-03. Long positions in SEC Section 13(f) securities; a lagged quarterly snapshot, filed up to 45 days after quarter-end. This filer has stopped filing 13F reports.
| 1 | GBT | GLOBAL BLOOD THERAPEUTICS INC |
| 2 | SAGE | SAGE THERAPEUTICS INC COM |
| 3 | BPMC | BLUEPRINT MEDICINES CORP |
| 4 | — | SESEN BIO, INC. |
| 5 | — | ZAFGEN INC |
Top holdings — weights and history with Pro
This 13F filer is outside the free plan's window — the 50 largest filers by portfolio value plus our curated roster of managers. It is in neither group. Unlock everything with Pro — $29.99/moSee it live on AAPL →